P. Neilsen

发表

Mutant p53 upregulates alpha-1 antitrypsin expression and promotes invasion in lung cancer

C. Ricciardelli, R. Shakya, G. Tarulli, 2017, Oncogene.

Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome

David F. Callen, David P. Lane, D. Lane, 2011, Oncotarget.

p53 Represses the Oncogenic Sno-MiR-28 Derived from a SnoRNA

David F. Callen, Gregory J. Goodall, C. Bracken, 2015, PloS one.

Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9

T. Lim, H. Gabra, D. Lane, 2013, Cell cycle.

Mutant p53 drives invasion in breast tumors through up-regulation of miR-155

C. Bracken, G. Goodall, P. A. Gregory, 2013, Oncogene.

Co-expression of the androgen receptor and the transcription factor ZNF652 is related to prostate cancer outcome.

J. Kench, D. Horsfall, J. Nesland, 2010, Oncology reports.

Systematic characterisation of the rat and human CYP24A1 promoter

P. Neilsen, D. Callen, P. Anderson, 2010, Molecular and Cellular Endocrinology.

Specific-site methylation of tumour suppressor ANKRD11 in breast cancer.

P. Neilsen, D. Callen, R. Suetani, 2012, European journal of cancer.

Development of a novel cell-based assay system EPISSAY for screening epigenetic drugs and liposome formulated decitabine

P. Neilsen, D. Callen, R. Suetani, 2013, BMC Cancer.

CBFA2T3-ZNF652 Corepressor Complex Regulates Transcription of the E-box Gene HEB*

G. Booker, P. Neilsen, D. Callen, 2008, Journal of Biological Chemistry.

Inhibition of DNA-Dependent Protein Kinase Induces Accelerated Senescence in Irradiated Human Cancer Cells

B. Solomon, G. McArthur, P. Neilsen, 2011, Molecular Cancer Research.

CBFA2T3–ZNF651, like CBFA2T3–ZNF652, functions as a transcriptional corepressor complex

P. Neilsen, D. Callen, R. Schulz, 2010, FEBS letters.

Pre-activation of the p53 pathway through Nutlin-3a sensitises sarcomas to drozitumab therapy.

M. Brown, K. Pishas, P. Neilsen, 2013, Oncology reports.

Ankrd11 is a chromatin regulator involved in autism that is essential for neural development.

S. Scherer, Mark Zander, P. Neilsen, 2015, Developmental cell.

P53 activation suppresses irinotecan metabolite SN-38-induced cell damage in non-malignant but not malignant epithelial colonic cells.

P. Neilsen, S. Smid, B. Gunasegaran, 2020, Toxicology in vitro : an international journal published in association with BIBRA.

Characterization of ANKRD11 mutations in humans and mice related to KBG syndrome

Juan I. Young, M. Tekin, F. Brancati, 2015, Human Genetics.

Antioxidative and therapeutic potential of selected Australian plants: A Review.

K. Walsh, P. Neilsen, N. Ashwath, 2020, Journal of ethnopharmacology.

A Template‐Based Approach to Inhibitors of Calpain 2, 20S Proteasome, and HIV‐1 Protease

B. Dunn, P. Neilsen, D. Callen, 2013, ChemMedChem.

New 26S proteasome inhibitors with high selectivity for chymotrypsin-like activity and p53-dependent cytotoxicity.

K. Pishas, P. Neilsen, D. Callen, 2013, ACS chemical biology.

Natural product-derived phytochemicals as potential agents against coronaviruses: A review

K. Walsh, P. Neilsen, J. Mani, 2020, Virus Research.

The Application of Delivery Systems for DNA Methyltransferase Inhibitors

P. Neilsen, D. Callen, A. Abell, 2011, BioDrugs.

Genome‐wide mapping of ZNF652 promoter binding sites in breast cancer cells

L. Selth, P. Neilsen, D. Callen, 2011, Journal of cellular biochemistry.

Ankrd11 is a chromatin regulator involved in autism that is essential for neural development

S. Scherer, Mark Zander, P. Neilsen, 2015, SpringerPlus.

TAp63 regulates oncogenic miR-155 to mediate migration and tumour growth

P. Neilsen, D. Callen, R. Suetani, 2013, Oncotarget.

The Oncogenic Role of miR-155 in Breast Cancer

P. Neilsen, D. Callen, R. Suetani, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells

A. Børresen-Dale, B. Tian, J. Bargonetti, 2015, Genes & development.

Mutant p 53 cooperates with the SWI / SNF chromatin remodeling complex to regulate VEGFR 2 in breast cancer cells

A. Børresen-Dale, B. Tian, J. Bargonetti, 2015 .

Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profiling.

David M. Thomas, J. Desai, G. Farshid, 2014, Cancer research.

Targeting the p53 Pathway in Ewing Sarcoma

David M. Thomas, K. Pishas, P. Neilsen, 2010, Sarcoma.

Nutlin-3a Is a Potential Therapeutic for Ewing Sarcoma

M. Brown, K. Pishas, P. Neilsen, 2010, Clinical Cancer Research.

Mutant p 53 drives invasion in breast tumors through up-regulation of miR-155 Oncogene

C. Bracken, G. Goodall, P. A. Gregory, 2015 .

Mutant p53 drives multinucleation and invasion through a process that is suppressed by ANKRD11

K. Khanna, P. Neilsen, D. Callen, 2012, Oncogene.

Identification of ANKRD11 as a p53 coactivator

P. Neilsen, D. Callen, R. Schulz, 2008, Journal of Cell Science.

Characterization of ANKRD11 mutations in humans and mice related to KBG syndrome

Juan I. Young, M. Tekin, F. Brancati, 2015, Human Genetics.

FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complex.

Anne-Marie Cleton-Jansen, Julie M Martin, A. Cleton-Jansen, 2005, Cancer research.

Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion

J. Norman, D. Lane, P. Timpson, 2012, Oncogene.

A comparison of vitamin D activity in paired non-malignant and malignant human breast tissues

J. Kollias, K. Pishas, P. Neilsen, 2012, Molecular and Cellular Endocrinology.

Synthesis and Anticancer Activities of 4-[(Halophenyl)diazenyl]phenol and 4-[(Halophenyl)diazenyl]phenyl Aspirinate Derivatives against Nasopharyngeal Cancer Cell Lines

P. Neilsen, Z. Ngaini, B. Lee, 2017 .

Nasopharyngeal carcinoma among the Bidayuh of Sarawak, Malaysia: History and risk factors

P. Neilsen, A. Khoo, D. Choo, 2021, Oncology letters.

In vitro cytotoxicity evaluation of thiourea derivatives bearing Salix sp. constituent against HK-1 cell lines

P. Neilsen, Z. Ngaini, Norsyafikah Asyilla Nordin, 2018, Natural product research.

Synthesis and extended activity of triazole-containing macrocyclic protease inhibitors.

M. Gütschow, P. Neilsen, D. Callen, 2013, Chemistry.

Ankrd11 is a chromatin regulator involved in autism that is essential for neural development.

S. Scherer, Mark Zander, P. Neilsen, 2015, SpringerPlus.

Ankrd11 is a chromatin regulator involved in autism that is essential for neural development.

S. Scherer, Mark Zander, P. Neilsen, 2015, Developmental cell.

Genome‐wide mapping of ZNF652 promoter binding sites in breast cancer cells

L. Selth, P. Neilsen, D. Callen, 2011, Journal of cellular biochemistry.

TAp63 regulates oncogenic miR-155 to mediate migration and tumour growth

P. Neilsen, D. Callen, R. Suetani, 2013, Oncotarget.

Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome

D. Lane, P. Neilsen, D. Callen, 2011, Oncotarget.

Nutlin-3a Is a Potential Therapeutic for Ewing Sarcoma

M. Brown, P. Neilsen, D. Callen, 2010, Clinical Cancer Research.

Synthesis and extended activity of triazole-containing macrocyclic protease inhibitors.

M. Gütschow, P. Neilsen, D. Callen, 2013, Chemistry.